Home / Recalls / Fagron Compounding Services / D-0636-2024

D-0636-2024 Class II Ongoing

Recalled by Fagron Compounding Services — Wichita, KS

Recall Details

Product Type
Drugs
Report Date
August 28, 2024
Initiation Date
August 15, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide in the USA

Code Information

Lot#: C274-000037397, C274-000037398, C274-000037399, C274-000037400, Exp. Date 10/14/2024.

Other recalls by Fagron Compounding Services

  • D-0221-2026 Class II — Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophth (November 20, 2025)
  • D-0646-2025 Class II — bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Do (August 29, 2025)
  • D-0225-2025 Class II — fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII, Single us (January 31, 2025)
  • D-0125-2024 Class III — Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25mg/ (November 10, 2023)